Celldex Therapeutics
CLDX
#4575
Rank
HK$18.39 B
Marketcap
HK$234.22
Share price
5.66%
Change (1 day)
32.86%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$34.11. In 2022 the company made an earnings per share (EPS) of -HK$18.74 a decrease over its 2021 EPS that were of -HK$12.86.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.810.37%
2022-HK$18.7445.73%
2021-HK$12.86-23.36%
2020-HK$16.78-41.05%
2019-HK$28.46-76.95%
2018-HK$123.5045.03%
2017-HK$85.16-42.54%
2016-HK$148.20-3.82%
2015-HK$154.08-0.76%
2014-HK$155.2629.41%
2013-HK$119.970%
2012-HK$119.97-9.73%
2011-HK$132.911312.5%
2010-HK$9.41-95.79%
2009-HK$223.30-49.64%
2008-HK$443.43-82.64%
2007-HK$2,555-44.98%
2006-HK$4,6441270.83%
2005-HK$338.7533.33%
2004-HK$254.06-10%
2003-HK$282.29-16.67%
2002-HK$338.75-38.46%
2001-HK$550.47-4.88%
2000-HK$578.70-81.66%
1999-HK$3,155-87.2%
1998-HK$24,636206.39%
1997-HK$8,04113.02%
1996-HK$7,115

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-117.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.19-472.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-HK$34.42 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$31.44-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$15.84-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$26.97-20.92%๐Ÿ‡บ๐Ÿ‡ธ USA